Peoples Financial Services CORP. Buys 2,050 Shares of iShares Core S&P 500 ETF (IVV)

Share on StockTwits

Peoples Financial Services CORP. increased its stake in iShares Core S&P 500 ETF (NYSEARCA:IVV) by 3,360.7% during the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 2,111 shares of the company’s stock after buying an additional 2,050 shares during the period. Peoples Financial Services CORP.’s holdings in iShares Core S&P 500 ETF were worth $531,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors also recently bought and sold shares of IVV. SigFig Wealth Management LLC grew its stake in shares of iShares Core S&P 500 ETF by 59.0% in the 2nd quarter. SigFig Wealth Management LLC now owns 82,852 shares of the company’s stock worth $22,623,000 after buying an additional 30,731 shares during the last quarter. Ironwood Wealth Management LLC. boosted its stake in iShares Core S&P 500 ETF by 0.4% during the 2nd quarter. Ironwood Wealth Management LLC. now owns 101,958 shares of the company’s stock valued at $27,840,000 after purchasing an additional 448 shares during the last quarter. FMR LLC boosted its stake in iShares Core S&P 500 ETF by 19.7% during the 2nd quarter. FMR LLC now owns 8,845,317 shares of the company’s stock valued at $2,415,213,000 after purchasing an additional 1,453,780 shares during the last quarter. United Services Automobile Association boosted its stake in iShares Core S&P 500 ETF by 111.7% during the 2nd quarter. United Services Automobile Association now owns 1,841,258 shares of the company’s stock valued at $502,756,000 after purchasing an additional 971,587 shares during the last quarter. Finally, Renaissance Technologies LLC purchased a new stake in iShares Core S&P 500 ETF during the 2nd quarter valued at $573,000.

IVV traded down $0.72 during trading on Monday, hitting $259.65. 133,044 shares of the company’s stock traded hands, compared to its average volume of 5,385,630. iShares Core S&P 500 ETF has a 12-month low of $235.46 and a 12-month high of $296.69.

The company also recently declared a quarterly dividend, which was paid on Friday, January 4th. Stockholders of record on Monday, December 31st were issued a dividend of $0.3223 per share. The ex-dividend date was Friday, December 28th. This represents a $1.29 annualized dividend and a dividend yield of 0.50%.

TRADEMARK VIOLATION NOTICE: This story was originally posted by Zolmax and is the property of of Zolmax. If you are reading this story on another publication, it was copied illegally and republished in violation of U.S. and international copyright laws. The legal version of this story can be viewed at https://zolmax.com/investing/peoples-financial-services-corp-buys-2050-shares-of-ishares-core-sp-500-etf-ivv/2824360.html.

iShares Core S&P 500 ETF Company Profile

iShares Core S&P 500 ETF (the Fund) is an exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Standard & Poor’s 500 Index (the Index). The Index measures the performance of the large-capitalization sector of the United States equity market.

Featured Story: How prevalent are 12b-1 fees?

Institutional Ownership by Quarter for iShares Core S&P 500 ETF (NYSEARCA:IVV)

Receive News & Ratings for iShares Core S&P 500 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Core S&P 500 ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

CIBT Education Group  Sets New 52-Week Low at $0.62
CIBT Education Group Sets New 52-Week Low at $0.62
Mercury Protocol 24-Hour Trading Volume Reaches $0.00
Mercury Protocol 24-Hour Trading Volume Reaches $0.00
Solarwindow Technologies  vs. Aemetis  Financial Survey
Solarwindow Technologies vs. Aemetis Financial Survey
Analyzing BIOQUAL  & Medpace
Analyzing BIOQUAL & Medpace
-$0.55 EPS Expected for ACADIA Pharmaceuticals Inc.  This Quarter
-$0.55 EPS Expected for ACADIA Pharmaceuticals Inc. This Quarter
Zacks: Analysts Expect Scotts Miracle-Gro Co  to Announce -$1.24 EPS
Zacks: Analysts Expect Scotts Miracle-Gro Co to Announce -$1.24 EPS


Leave a Reply

 
© 2006-2019 Zolmax.